1. Home
  2. ARBB vs NXL Comparison

ARBB vs NXL Comparison

Compare ARBB & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ARB IOT Group Limited

ARBB

ARB IOT Group Limited

HOLD

Current Price

$4.68

Market Cap

6.9M

Sector

Technology

ML Signal

HOLD

Logo Nexalin Technology Inc.

NXL

Nexalin Technology Inc.

HOLD

Current Price

$0.37

Market Cap

7.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARBB
NXL
Founded
1997
2010
Country
Singapore
United States
Employees
N/A
8
Industry
EDP Services
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.9M
7.2M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
ARBB
NXL
Price
$4.68
$0.37
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$20.00
N/A
AVG Volume (30 Days)
23.8K
191.5K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$15.52
Revenue Next Year
$24.79
$100.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.46
$0.31
52 Week High
$13.89
$2.00

Technical Indicators

Market Signals
Indicator
ARBB
NXL
Relative Strength Index (RSI) 51.59 51.63
Support Level $3.91 $0.35
Resistance Level $5.24 $0.46
Average True Range (ATR) 0.38 0.03
MACD -0.02 0.01
Stochastic Oscillator 43.64 36.24

Price Performance

Historical Comparison
ARBB
NXL

About ARBB ARB IOT Group Limited

ARB IOT Group Ltd is a provider of complete solutions to the clients for the integration of Internet of Things (IoT) systems and devices from designing to project deployment. The company offers a wide range of IoT systems as well as provides customers with a substantial range of services such as system integration and system support services. It delivers solutions like designing, installation, testing and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company operates in two reportable segments: (i) the provision of hardware and software of IoT solutions and (ii) Investment holding and others. The majority of revenue is generated from the IoT solutions segment.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Share on Social Networks: